SCHEMBL4154203

SCHEMBL4154203

CN(C(=O)N(C(=O)c1c(F)cccc1F)N1CCOCC1)c1ccc(SC(F)(F)F)cc1F

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.34
CASR P41180 1/20 0.34
RAB9A P51151 2/20 0.32
NPC1 O15118 1/20 0.32
FKBP1A P62942 1/20 0.32
ALDH1A1 P00352 1/20 0.32
ABL1 P00519 1/20 0.32
BCR P11274 1/20 0.32
PIK3CA P42336 1/20 0.31
ITGB2 P05107 1/20 0.31
ICAM1 P05362 1/20 0.31
ITGAL P20701 1/20 0.31
P2RX7 Q99572 2/20 0.31
RORC P51449 1/20 0.31
TACR1 P25103 1/20 0.31
TP53 P04637 1/20 0.31
TRPV4 Q9HBA0 1/20 0.30
GPBAR1 Q8TDU6 1/20 0.30
MLYCD O95822 1/20 0.30
POLB P06746 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4636499 0.90 CASR (0.33) CASRFKBP1APIK3CAGPBAR1
SCHEMBL4160290 0.84 MAPK1 (0.45) MAPK1CASRALDH1A1TACR1
SCHEMBL4153945 0.81 RORC (0.31) MAPK1ALDH1A1P2RX7RORC
SCHEMBL4154435 0.81 RORC (0.36) MAPK1RORCGPBAR1POLB
SCHEMBL4156743 0.79 RORC (0.35) MAPK1RORCGPBAR1POLB
SCHEMBL13774525 0.78 RORC (0.32) PIK3CARORC
SCHEMBL4144806 0.78 RORC (0.35) MAPK1RORCGPBAR1POLB
SCHEMBL4142611 0.78 RORC (0.35) MAPK1RORCGPBAR1POLB
SCHEMBL4157996 0.78 RORC (0.35) MAPK1RORCPOLB
SCHEMBL4158550 0.77 RORC (0.33) MAPK1RAB9AALDH1A1RORCGPBAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 MAPK1 973/4885CASR 1722/4885RAB9A 642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.